USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth

Participants:

Charlotte Turnier VP, Enterprise Key Account ManagementCertara
Charlotte Turnier
VP, Enterprise Key Account ManagementCertara
Francois-Henri BOISSEL Co-founder & CEONOVADISCOVERY
Francois-Henri BOISSEL
Co-founder & CEONOVADISCOVERY
Armin Furtwaengler Global Medical Lead Innovation Scouting Boehringer Ingelheim International GmbH
Armin Furtwaengler
Global Medical Lead Innovation Scouting Boehringer Ingelheim International GmbH
Doina Sirbu Medical Device Innovation LeadUCB Pharma
Doina Sirbu
Medical Device Innovation LeadUCB Pharma
Dominik Boeke President, Pharma BusinessSidekick Health
Dominik Boeke
President, Pharma BusinessSidekick Health
JM
john mattison CMIOACP
JM
john mattison
CMIOACP
John Mattison resident scholarucsd
John Mattison
resident scholarucsd
Laura Joglekar Senior Director, Material SciencesBristol Myers Squibb
Laura Joglekar
Senior Director, Material SciencesBristol Myers Squibb
Troy Osetek Senior Director of Business OperationsBristol Myers Squibb
Troy Osetek
Senior Director of Business OperationsBristol Myers Squibb

About this Meeting

Clinical trials are expensive to conduct and it can be a real challenge to recruit the right patients. For this reason, in the last few years, in silico clinical trials have gained traction, as modeling and simulation can improve R&D outcomes, timelines, making trials more efficient, cheaper and less risky. Join us in this Masterclass led by Novadiscovery to learn more about: 
-How can these predictive methodologies strengthen and optimize Clinical         Development and Market Access decisions? 
 -Authorities’ acceptance of in silico data generation 
 -Best therapeutic areas to use modeling and simulation 
 -Real examples on how to do it